ALKİM ALKALİ KİMYA A.Ş. — Proxy Solicitation & Information Statement 2026

Mar 10, 2026

ALKIM ALKALI KIMYA JOINT STOCK COMPANY

INVITATION TO THE ORDINARY GENERAL ASSEMBLY MEETING DATED APRIL 09, 2026

The Ordinary General Assembly Meeting, where our Company's 2025 activities will be discussed, will be held on Thursday, April 09, 2026, at 14:00, at The Marmara Hotel Taksim Square / Istanbul, to discuss and decide on the agenda items.

Shareholders can attend our Company's Ordinary General Assembly Meeting in person, either physically or electronically, or through their representatives. Participation in the General Assembly in an electronic environment is possible with the secure electronic signatures of shareholders or their representatives. Therefore, shareholders who will conduct transactions in the Electronic General Assembly System (EGKS) must first register on the Central Registry Agency Inc. (MKK) e-MKK Information Portal and record their contact information, as well as having a secure electronic signature. Shareholders or representatives who are not registered on the e-MKK Information Portal and do not have secure electronic signatures cannot participate in the General Assembly in an electronic environment.

In addition, shareholders or their representatives who wish to participate in the meeting electronically must fulfill their obligations in accordance with the provisions of the "Regulation on General Assemblies to be Held Electronically in Joint-Stock Companies" published in the Official Gazette dated August 28, 2012 and numbered 28395, and the "Communiqué on the Electronic General Assembly System to be Applied in General Assemblies of Joint-Stock Companies" published in the Official Gazette dated August 29, 2012 and numbered 28396.

Shareholders who cannot attend the meeting in person, either physically or electronically, must prepare their proxies in accordance with the requirements or obtain a proxy form sample from our Company Headquarters or the Company's website at www.alkim.com, and submit their proxies with notarized signatures by fulfilling the requirements set forth in the Capital Markets Board's Communiqué numbered II-30.1 on "Using Votes by Proxy and Gathering Proxies by Call". Shareholders who wish to attend the General Assembly in person in a physical environment will be able to exercise their rights regarding their shares registered in the "Shareholders List" in the Central Registry Agency (CRA) system by presenting their ID.

Our shareholders who will attend the general assembly electronically via the Electronic General Assembly System can obtain information about the procedures and principles regarding participation, appointment of representatives, making proposals, expressing opinions and voting from the Central Registry Agency's internet address https://www.mkk.com.tr.

The Management and Independent Audit Institution Reports, Financial Tables and the Board of Directors' proposal regarding the distribution of profits for the 2025 activity year will be accessible from the Electronic General Assembly System, from the "Investors" page of our company's www.alkim.com address at least three weeks before the General Assembly meeting date, and will also be made available for the examination of the partners at our Company's Company Headquarters located at İnönü Cad. No:13 Taksim Beyoğlu/İstanbul Turkey.

It is submitted for the information of our esteemed shareholders.

M. REHA KORA Chairman of the Board of Directors

---

AGENDA OF THE ANNUAL ORDINARY GENERAL ASSEMBLY MEETING TO BE HELD ON APRIL 09, 2026

1. Opening and formation of the Meeting Presidency
2. Reading and discussion of the Board of Directors Activity Report for the 2025 accounting period
3. Reading of the Independent Audit Institution Report for the 2025 accounting period
4. Reading, discussion and approval of the Financial Statements for the 2025 accounting period
5. Reading and discussion of the TSRS-compliant Sustainability Report for the 2024 fiscal year.
6. Approval of the selection of the Independent Audit Institution for the 2026 Accounting Period
7. Approval of the selection of the Sustainability Report Assurance Audit Firm for the 2026 fiscal year.
8. Discharge of the members of the Board of Directors from the company's activities, transactions and accounts for the 2025 accounting period
9. Informing the shareholders about the "Remuneration Policy" of the members of the Board of Directors and senior executives in accordance with the regulations of the Capital Markets Board
10. Determination of monthly gross salaries and attendance fees of Board Members,
11. Discussion and decision on the proposal of the Board of Directors regarding the distribution of profits for the accounting period of 2025
12. Authorization of the Board of Directors for the sale of some or all of the shares of our Company's affiliate (subsidiary) traded on Borsa Istanbul A.Ş. (BIST)
13. Authorization of the Board of Directors for the sale of our Company's General Directorate Building located at İnönü Cad. No:13 Taksim Beyoğlu Istanbul,
14. Informing shareholders about donations and aids made in 2025, determining an upper limit for donations and aids to be made in 2026.
15. Informing shareholders about the collateral, pledges, mortgages and sureties given by the Company in favor of third parties in 2025
16. Granting permission to shareholders who have control over the management, members of the Board of Directors, executives with administrative responsibility and their spouses and blood and in-law relatives up to the second degree within the framework of Articles 395 and 396 of the Turkish Commercial Code and the regulations of the Capital Markets Board, and informing shareholders about the transactions carried out within this scope in the 2025 accounting period
17. Providing information to shareholders about the Related Party Transactions prepared within the framework of Article 9 of the Corporate Governance Communiqué No. II-17.1 published by the Capital Markets Board of our Company
18. Wishes and requests

---

POWER OF ATTORNEY

ALKIM ALKALI KIMYA ANONIM ŞİRKETİ

I hereby appoint as proxy, who is introduced in detail below, to represent me, vote, make proposals and sign the necessary documents in the 2025 Ordinary General Assembly Meeting of Alkim Alkali Kimya A.Ş. to be held on Thursday, April 9, 2026, at 14:00 at The Marmara Hotel Taksim Square Beyoğlu Istanbul, in line with the views I have stated below.

Proxies' (*);

Name Surname/Trade Name:

TC Identity Number/Tax Number, Trade Registry and Number and MERSES number:

(*) For foreign proxies, it is mandatory to submit the equivalents of the mentioned information, if any.

A) SCOPE OF REPRESENTATIVE AUTHORITY

For sections 1 and 2 below, one of the options (a), (b) or (c) should be selected to determine the scope of the representative authority.

1. Regarding the Issues on the Agenda of the General Assembly;

a) The proxy is authorized to vote in accordance with his/her own opinion.
b) The proxy is authorized to vote in accordance with the recommendations of the partnership management.
c) The proxy is authorized to vote in accordance with the instructions specified in the table below.

Instructions:

If option (c) is selected by the shareholder, the instructions specific to the agenda item are given by marking one of the options given opposite the relevant general assembly agenda item (accept or reject) and, if the reject option is selected, by indicating the dissenting opinion requested to be written in the general assembly minutes, if any.

---

PROXY

ALKIM ALKALI KIMYA ANONIM ŞİRKETİ

I hereby appoint ..., introduced below in a detailed manner, as my proxy authorized to represent me, cast vote, submit proposals and sign necessary documents in line with the opinions I have specified below during the Ordinary General Meeting of Alkim Alkali Kimya A.Ş. to be held on 09 April 2026, at 14.00 at The Marmara Hotel, Taksim Square, Istanbul.

Proxy’s (*);

Name & Surname/Corporate Name:

Turkish ID No./Tax ID No., Trade Registry Office and Trade Registration Number and, MERSİS Number:

(*) For the foreign national proxies, the equivalent of the said information must be submitted.

A) SCOPE OF THE POWER OF REPRESENTATION

For the following sections 1 and 2, one of the options (a), (b) or (c) must be selected to identify the scope of the power of representation.

1. Concerning the Agenda Items of the General Meeting;
   a) The Proxy is authorized to cast vote in line with their own opinion.
   b) The Proxy is authorized to cast vote in line with the recommendations of the company’s management.
   c) The Proxy is authorized to cast vote in line with the instructions specified on the following table.

Instructions:

In case a shareholder selects the option (c), the instructions on an agenda item are given by means of choosing one of the options concerning that agenda item of the general meeting (acceptation or refusal) and if the refusal option is selected, then the instructions are given by means of specifying the dissenting options requested to be indicated on the minutes of the general meeting.

---

Agenda Items (*)	Accept	Refuse	Dissenting Option
1. Opening and, formation of the Chairman of the Meeting
2. Reading and deliberation on the Annual Report of the Board of Directors for the accountancy period of 2025
3. Reading the Report of the Independent AuditingFirm for the accountancy period of 2025
4. Reading, deliberation on and approval of the Financial Statements for the accountancy period of 2025
5. Reading and discussion of the TSRS-compliant Sustainability Report for the 2024 fiscal year.
6. Approval of the selection of the Independent Audit Institution for the 2026 Accounting Period
7. Approval of the selection of the Sustainability Report Assurance Audit Firm for the 2026 fiscal year.
8. Discharge of the members of the Board of Directors from the company's activities, transactions and accounts for the 2025 accounting period
9. Informing the shareholders about the "Remuneration Policy" of the members of the Board of Directors and senior executives in accordance with the regulations of the Capital Markets Board
10. Determination of monthly gross salaries and attendance fees of Board Members
11. Discussion and decision on the proposal of the Board of Directors regarding the distribution of profits for the accounting period of 2025
12 Authorizing the Board of Directors to sell all or a portion of the shares of the affiliate (subsidiary) of our company traded at Borsa Istanbul A.Ş.'de (BIST)
13. Authorizing the Board of Directors to sell the building of the General Office of our company located in İnönü Cad. No:13 Taksim Beyoğlu Istanbul

---

14. Informing the General Assembly Regarding the Donation and Contributions made in 2025 and resolving the limitations to be made in 2026.
15. Informing the shareholders of the guarantees, liens, mortgages and securities granted by our company in favor of 3rd parties in 2025
16. Granting permission to the shareholders controlling the management, the members of the Board of Directors, the executives with administrative responsibilities and, their spouses and relatives by blood and by marriage up to second degree as per the articles 395 and 396 of the Turkish Commercial Code and, the regulations of the Capital Market Board and, informing the shareholders of the transactions carried out in this scope within the accounting period of 2025
17. Providing information to shareholders about our Company's Related Party Transactions prepared of Article 9 of the Corporate Governance Communique numbered II-17.1 published by the Corporate Markets Board
18. Wishes and requests

(*) All the items on the agenda of the General Meeting are individually listed. In case there is separate resolution draft of the minority, then this will be separately indicated to allow for voting by proxy.

1. Special instruction concerning other issues that may arise during the General Meeting, in particular, the use of the minority rights:

a) The Proxy is authorized to cast vote in line with their own opinion.
b) The Proxy is not authorized in these issues.
c) The Proxy is authorized to cast vote in line with the following special instructions.

SPECIAL INSTRUCTIONS; the special instructions if any given by the principal to the proxy are specified here.

B) The shareholder specifies the shares the shareholder wants the proxy to represent by means of selecting one of the following options.

1. I hereby approve that the proxy will represent my shares, the details of which are provided below.

a) Order and serial: *
b) Number/Group: **

---

c) Quantity-Nominal value:

ç) Voting right share or not:

d) Bearer or Registered shares: *

e) Ratio to the total shares/voting rights the principle holds:

*This information is not requested for the shares monitored on records.

**For the shares monitored on records, the respective group will be specified instead of the number.

1. I hereby approve that the proxy will represent all of my shares that appear on the list of shareholders eligible to attend the general meeting as prepared by the CRA one day before the general meeting.

SHAREHOLDER’S NAME & SURNAME or CORPORATE NAME (*)

Turkish ID No. / Tax ID No., Trade Registry Office and Trade Registration Number and, MERSİS Number:

Address:

(*) For the foreign national shareholders, the equivalent of the said information must be submitted.